Search for: "R-R Drugs, Inc." Results 1 - 20 of 5,176
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
According to the Wall Street Journal, Pfizer Inc released a public statement on Saturday, January 6, 2018, announcing the end of R & D for new drugs for treatment of Alzheimer's Disease and Parkinson's Disease. [read post]
30 Apr 2007, 9:59 pm
Ortho-McNeil Pharmaceutical, Inc. is recalling glass bottles of GRIFULVIN V(R) griseofulvin oral suspension (liquid) due to glass fragments found in some bottles. [read post]
13 Jun 2014, 4:11 am by Matrix Legal Information Team
The post Case Previews: R (Sandiford) v SSFCA, AIB Group v MRC, Les Laboratoires Servier v Apotex Inc and VB v Westminster Magistrates’ Court appeared first on UKSCBlog. [read post]
22 Dec 2014, 10:58 pm
Pliva, Inc., a defective drugs case from the United States Court of Appeals for the Eighth Circuit, involved plaintiff whose doctor prescribed the brand-name drug Reglan to treat her Gastro Esophageal Reflux Disease (GERD). [read post]
26 Aug 2015, 12:53 pm by Bloomberg
Bethesda-based Sucampo Pharmaceuticals Inc. agreed to acquire Japan’s R-Tech Ueno Ltd. in a deal valued at about $276 million (33 billion yen), buying a company controlled by Sucampo’s founders that manufactures all of its drugs. [read post]
4 Jan 2016, 7:49 am by Law Offices of Jeffrey S. Glassman
Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits appeared first on Product Liability Lawyer Blog. [read post]
7 Mar 2007, 11:03 pm
Launched in conjunction with the Drug Information Association's (DIA) 20th Annual Conference for Electronic Document Management (EDM) in Philadelphia, the QUMAS R&D Suite is already gaining traction within the life sciences industry. [read post]
7 Jun 2018, 4:59 pm by Patent Docs
Celltrion had initiated the dispute between the parties by filing complaints for declaratory judgment with respect to patents related to Genentech's Herceptin and Rituxan biologic drugs. [read post]
16 Jan 2014, 9:41 pm by Patent Docs
Athena Cosmetics, Inc. provides the answer: these products comprise prostaglandin derivatives. [read post]
29 Jul 2021, 11:02 am by Dennis Crouch
by Dennis Crouch Amarin Pharma, Inc. v. [read post]
11 Mar 2011, 8:46 am by Antitrust Today
(“HGS”) is asking a federal court in Delaware to find that rival drug developer Genentech Inc. has violated U.S. antitrust laws by colluding with Celltech R&D Ltd. to fraudulently extend the life of a disputed patent. [read post]
12 Jun 2017, 9:59 pm by Patent Docs
Amgen Inc., marking the first time the Court has interpreted the Biologics Price Competition and Innovation Act ("BPCIA") for the approval of biosimilar drugs. [read post]
17 Jun 2012, 9:55 pm by Patent Docs
Searle, LLC • Defendants: Hetero Drugs, Ltd., Unit III; Invagen Pharmaceuticals, Inc. [read post]